GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 177 filers reported holding GENMAB A/S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,849 | -12.0% | 9,182 | -5.2% | 0.02% | -4.5% |
| Q2 2023 | $368,127 | +12.9% | 9,685 | +12.2% | 0.02% | +4.8% |
| Q1 2023 | $325,944 | +16.7% | 8,632 | +31.0% | 0.02% | 0.0% |
| Q4 2022 | $279,242 | -9.0% | 6,589 | -30.9% | 0.02% | -30.0% |
| Q3 2022 | $307,000 | -1.3% | 9,542 | -0.3% | 0.03% | +3.4% |
| Q2 2022 | $311,000 | -22.1% | 9,570 | -13.3% | 0.03% | -6.5% |
| Q1 2022 | $399,000 | +6.1% | 11,036 | +28.4% | 0.03% | -20.5% |
| Q3 2021 | $376,000 | – | 8,595 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |